Navigation Links
Life Sciences Discovery Fund helps launch 3 programs to advance health research and development
Date:6/28/2011

SEATTLE, Washington, JUNE 27, 2011 The Life Sciences Discovery Fund (LSDF) today announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. LSDF will allocate up to $8 million among the three programs.

The programs will be led by University of Washington investigators in partnership with collaborators across the state. Dr. David Flum will work with health-care providers, insurers, and information technology experts to create databases of clinical practices, patient outcomes, and medical costs that can be used to assess the comparative effectiveness and cost effectiveness of specific health-care strategies. This work builds upon an LSDF project grant that Dr. Flum received in 2007.

A second program, led by Dr. Michael Schwartz, will develop new human stem cell-based treatments for type 1 diabetes that avoid the problems of tumor formation and immune rejection that have previously limited the use of such therapies. The research team anticipates that their treatment approach can ultimately be applied to other diseases.

The third program, directed by Dr. John Slattery, will establish a system for collection and statewide distribution of human biological specimens required to answer important research questions and ultimately improve disease diagnosis and treatment. The specimens will be linked to biologically relevant data on the donors, and the program will be constructed to protect patient privacy and rights. This program will complement the cancer biospecimen resource that Dr. Peggy Porter of the Fred Hutchinson Cancer Research Center is developing under an LSDF 2009 program grant.

The three awards were made in the 2010 program grant competition, which supports the launch of new collaborative initiatives that address major health problems and position organizations for future competitiveness and leadership.

According to LSDF executive director Lee Huntsman, the new cohort of awards is anticipated to reap health and economic impacts that are broad in both magnitude and scope. "In addition to improving treatment of a specific conditionnamely, type 1 diabetesthese grants will create robust resources to accelerate development of diagnostics and therapies for a multitude of diseases."

Huntsman added that "the grant to Dr. Flum will allow Washington's health-care community to answer vital questions regarding the value of various treatments and determine the best uses of our limited health-care dollars."

The LSDF board of trustees selected the awardees from 11 proposals that were evaluated by national experts convened by the American Association for the Advancement of Science. In a highly competitive two-phase process, proposals were rated on scientific merit and the potential to improve health and health care in Washington and provide statewide economic benefit.

Lura Powell, chair of the LSDF board of trustees, noted that the impact of the new awards would likely be felt throughout Washington. "These grants support cutting-edge research as well as widespread distribution of high-quality specimens and health-care data. Together, they will help ensure that our state maintains its leadership position in medical research and delivery of cost-effective health care."


'/>"/>

Contact: Alden Jones
aldenj2@uw.edu
206-732-6770
Life Sciences Discovery Fund
Source:Eurekalert

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. Aerospace sciences meeting to be held Jan. 5-8 in Orlando
3. Natural and social sciences: ICSU embraces the need to work more closely together
4. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
5. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
6. The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen
7. Life Sciences Discovery Fund awards health research program grants
8. Springer expands its portfolio in plant sciences with Phytoparasitica
9. Mycotoxin Research joins Springers life sciences journals program
10. NTU seals global partnerships on environmental sciences R&D
11. The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology: